Abstract: A sensing block includes a block body having a plurality of slots through which electrode leads of battery cells pass, a plurality of sensing terminals installed between the plurality of slots on a front surface of the block body, a circuit board installed on the front surface of the block body, and a connector installed on the circuit board.

Abstract: A battery cell cartridge in which a battery cell is accommodated, includes first, second, third and fourth frames formed in a quadrangular shape, wherein the first frame and the second frame extend along a horizontal direction and are spaced from each other at a predetermined interval therebetween, the first frame is positioned on an upper side and the second frame is positioned on a lower side, the third frame and the fourth frame extend along a vertical direction and are spaced from each other at a predetermined interval therebetween, and the third frame is positioned on a first side and the third frame is positioned on a second side opposite to the second frame.

Abstract: Disclosed is a case for a battery module including a body having an internal space; and an end plate disposed on an end of the body, wherein the body includes a bottom plate on which a coolant flow path through which a coolant flows is formed, and wherein the end plate includes a coolant flow tube through which the coolant flows and a connection portion extending from the coolant flow tube and coupled to the coolant flow path.

Abstract: An embodiment battery module includes a plurality of battery cells provided as a pouch type, a plurality of cartridges, each of the cartridges holding the battery cells that are adjacent to each other and form a pair, a sensing block coupled to a lateral side of the plurality of cartridges to bind the plurality of cartridges to each other, the sensing block including a first connector configured to electrically connect the plurality of battery cells and a second connector configured to measure voltage of the plurality of battery cells, and a lateral cover coupled to an outward side of the sensing block to bind the sensing block and the plurality of cartridges to each other, the lateral cover including a first opening that exposes the first connector to an outside and a second opening that exposes the second connector to the outside.

Abstract: This disclosure relates to managing diabetic neuropathy using compounds disclosed herein. In certain embodiments, this disclosure relates to methods of treating or preventing vascular conditions such as diabetic neuropathy comprising administering a compound capable of epigenetic modification, such as histone deacetylase inhibitors, to a subject in need thereof. In certain embodiments, this disclosure relates to the use of HDAC inhibitors to treat directly diabetic neuropathies and pain without the use of progenitor cells or stem cells. In certain embodiments, the subject is at risk of, exhibiting symptoms of, or diagnoses with diabetes, diabetic neuropathy, peripheral neuropathy, autonomic neuropathy, radiculoplexus neuropathy, mononeuropathy, diabetic retinopathy, or complications related thereto. In certain embodiments, the compound is selected from belinostat, quisinostat, and vorinostat.

Abstract: A monitoring device for managing at least one applicator fixture mounted on an applicator which has a magnetic body and connects a terminal to wiring via up and down movement. The monitoring device having a magnetic sensor which is mounted on the applicator and senses the movement of the magnetic body. At least one slave module receives identification information of the applicator fixture and mobility information of the magnetic body sensed by the magnetic sensor. A master module receives the identification information of the applicator fixture and the mobility information of the magnetic body in real time from the at least one slave module, while an interface module generates a monitoring interface indicating the degree of use of at least one applicator fixture by using the identification information of the applicator fixture and the mobility information of the magnetic body.

Abstract: This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, methods of treating or preventing vascular or diabetic diseases or conditions are contemplated. In certain embodiments, epigenetically reprogramming adult bone marrow-derived stem or progenitor cells including mesenchymal stem cells (MSCs) or endothelial progenitor cells (EPCs) for autologous treatments are contemplated.

Abstract: The present invention provides a monitoring device for managing at least one applicator fixture mounted on an applicator which has a magnetic body and connects a terminal to wiring via up and down movement, the monitoring device comprising: a magnetic sensor which is mounted on the applicator and senses the movement of the magnetic body; at least one slave module which receives identification information of the applicator fixture and mobility information of the magnetic body sensed by the magnetic sensor; a master module which receives the identification information of the applicator fixture and the mobility information of the magnetic body in real time from the at least one slave module; and an interface module that generates a monitoring interface indicating the degree of use of at least one applicator fixture by using the identification information of the applicator fixture and the mobility information of the magnetic body.

Abstract: A level shifter may include: a phase controller configured to determine the number of phases of a gate pulse, using an on input signal and an off input signal, and generate a control signal according to the determined number; a switching controller configured to generate one or more switching signals in response to the control signal; and an output buffer configured to generate the level-shifted gate pulse in response to the one or more switching signals.

Abstract: A power switching circuit and a method for controlling the same are disclosed herein. The power switching circuit includes a frequency control circuit, a pulse modulation circuit, and a switching convertor. The frequency control circuit receives a first reference signal driving a load, from a timing controller, and generates a second reference signal based on the first reference signal. The pulse modulation circuit generates a pulse control signal by performing pulse width modulation (PWM) or pulse frequency modulation (PFM) on the second reference signal. The switching convertor generates the voltage of output power by switching a switching element connected to the output power, in response to the pulse control signal. The pulse control signal is synchronized with the first reference signal driving the load.

Abstract: This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, methods of treating or preventing vascular or diabetic diseases or conditions are contemplated. In certain embodiments, epigenetically reprogramming adult bone marrow-derived stem or progenitor cells including mesenchymal stem cells (MSCs) or endothelial progenitor cells (EPCs) for autologous treatments are contemplated.

Abstract: A power switching circuit and a method for controlling the same are disclosed herein. The power switching circuit includes a frequency control circuit, a pulse modulation circuit, and a switching convertor. The frequency control circuit receives a first reference signal driving a load, from a timing controller, and generates a second reference signal based on the first reference signal. The pulse modulation circuit generates a pulse control signal by performing pulse width modulation (PWM) or pulse frequency modulation (PFM) on the second reference signal. The switching convertor generates the voltage of output power by switching a switching element connected to the output power, in response to the pulse control signal. The pulse control signal is synchronized with the first reference signal driving the load.

Abstract: This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, the disclosure contemplates inducing cells, such as adult somatic cells or cells that are not naturally pluripotent, into cells with chemically induce pluripotency. In certain embodiments, the disclosure contemplates certain compounds disclosed herein, compounds disclosed herein optionally substituted with one or more substituents, derivatives, or salts thereof, for these purposes.

Abstract: A level shifter may include: a phase controller configured to determine the number of phases of a gate pulse, using an on input signal and an off input signal, and generate a control signal according to the determined number; a switching controller configured to generate one or more switching signals in response to the control signal; and an output buffer configured to generate the level-shifted gate pulse in response to the one or more switching signals.

Abstract: This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, methods of treating or preventing vascular or diabetic diseases or conditions are contemplated. In certain embodiments, epigenetically reprogramming adult bone marrow-derived stem or progenitor cells including mesenchymal stem cells (MSCs) or endothelial progenitor cells (EPCs) for autologous treatments are contemplated.

Abstract: This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, the disclosure contemplates inducing cells, such as adult somatic cells or cells that are not naturally pluripotent, into cells with chemically induce pluripotency. In certain embodiments, the disclosure contemplates certain compounds disclosed herein, compounds disclosed herein optionally substituted with one or more substituents, derivatives, or salts thereof, for these purposes.

Abstract: Disclosed herein is a fully passive decay heat removal system utilizing a partially immersed heat exchanger, the system comprising: a hot pool; an intermediate heat exchanger which heat-exchanges with the sodium of the hot pool; a cold pool; a support barrel extending vertically through the boundary between the hot pool and the cold pool; a sodium-sodium decay heat exchanger received in the support barrel; a sodium-air heat exchanger provided at a position higher than the sodium-sodium decay heat exchanger; an intermediate sodium loop connecting the sodium-sodium decay heat exchanger with the sodium-air heat exchanger; and a primary pump, wherein a portion of the effective heat transfer tube of the sodium-sodium decay heat exchanger is immersed in the cold pool, particularly in a normal operating state, and the surface of the lower end of a shroud for the sodium-sodium decay heat exchanger, the lower end being immersed in the sodium of the cold pool, has perforated holes.

Abstract: A terminal device for a cellular phone is provided. A video displayed in the terminal display unit of a portable terminal can be enlarged and displayed in the unit display unit of a display unit, and a variety of functions of the portable terminal can be used through the display unit.

Abstract: Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment of an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.

Abstract: The present invention relates generally to a method and apparatus for providing a virtual mobile phone number, and, more particularly, to a method and apparatus for requesting routing information, such as an actual phone number from a home location register storing the actual phone number corresponding to a virtual phone number transmitted from an originating terminal and transmitting a short message, a long message or a multimedia message to a terminating terminal corresponding to the actual phone number.